GSK removes zinc from denture cream
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline says it will remove zinc from its denture creams, including Super PoliGrip Original, Ultra Fresh and Extra Care, as a "voluntary, precautionary action" in response to potential health risks related to "long-term, excessive" use of the mineral. The consumer warning and reformulation come after the company received around 400 reports of neurological symptoms associated with the products between 1996 and 2009. According to a Feb. 19 press release from the Great Neck, N.Y.-based firm Parker Waichman Alonso, lawyers representing clients in a class action lawsuit against Glaxo for allegedly failing to warn consumers of the risk applaud the change and urge the firm to recall the products "given their devastating impact on consumers," (1"The Tan Sheet" Oct. 9, 2009). The law firm also urged Procter & Gamble to remove zinc from its denture cream Fixodent. P&G did not return a call prior to deadline. Both firms assure consumers that the creams are safe when used as directed
You may also be interested in...
Glaxo Promotes Reformulated Poligrip With Focus On Comfort, Confidence
With the number of denture-wearers increasing, GlaxoSmithKline launches its Super Poligrip denture cream line reformulated without zinc, an adhesive ingredient that has drawn lawsuits and negative press
Zinc Lawsuits, Recalls May Taint Mineral's Image
Lawsuits alleging that zinc in two popular denture creams damages nerves, combined with the recent recall of some zinc-containing Zicam products, could call into question the use of the mineral, which trade groups insist is safe when taken appropriately
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”